Company / Tangible Book Value per Share
Arcadia Biosciences, Inc. Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$4.56
FY2025
5-year range
$2.31 / $37.92
FY2021-FY2025
Trend
-53.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Tangible Book Value per Share has declined for 3 consecutive years, from $37.92 in FY2022 to $4.56 in FY2025.
Based on SEC 10-K filings.
4.56 in FY2025 with a 5-year CAGR of +7.6%.
Declined from $20.84 to $4.56 over the past 2 years.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -50.6%
- 5-Year CAGR
- +7.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- Arcadia Biosciences, Inc.'s tangible book value per share has declined for 3 consecutive years.
- In FY2025, tangible book value per share decreased 53.9% year-over-year.
- Peak tangible book value per share was recorded in FY2022.
- Lowest tangible book value per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 7.60 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.56 | -53.9% |
| FY2024 | $9.88 | -52.6% |
| FY2023 | $20.84 | -45.0% |
| FY2022 | $37.92 | +1540.6% |
| FY2021 | $2.31 | -26.8% |
| FY2020 | $3.16 | +95.8% |
| FY2019 | $1.61 | -57.0% |
| FY2018 | $3.75 | -62.4% |
| FY2017 | $9.98 | +996.2% |
| FY2016 | $0.91 | +102.2% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026